interferons side effects are gruelling
ThymusMessagesInterferonDonationsContact UsComplete Alternative Medicine Solution PharmacyHepatitis C PharmacyLloyd's HCV Book Chapters

On The Radio

Book Reviews
Order Book

Herb schedule

Fax Order Form

Read About:
Aloe Vera
Milk Thistle
Vitamin C
NatCell Thymus
NatCell Liver
NatCell TLM
NatCell Mesenchyme
Lipoic Acid
Licorice Root
Cats Claw
Dandelion Root
Olive Leaf


Shop Now





Standard Therapy 
Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B  hepatitis with recombinant human alpha interferon: A preliminary report. New  Engl J Med 1986; 315:1575-1578.
Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with  recombinant interferon alpha: A multicenter randomized, controlled trial. New  Engl J Med 1989; 321:1501-1506.
Marcellin P, Boyer N, Giostra, et al. Recombinant human alpha- interferon in  patients with chronic non A non B hepatitis: a multicenter randomized controlled  trial from France. Hepatology 1991; 13:393-397.
Causse x, Godinot H, Ouzan D, et al. Comparison of 1 or 3 MU of interferon  alfa-2b and placebo in patients with chronic non-A non-B hepatitis.  Gastroenterology 1991; 101:497-502.
TinĊ½ F, Margin S, Craxi A, Pagliaro L. Interferon for non-A, non- B chronic  Hepatitis: a meta-analysis of randomized clinical trials. J Hepatol 1991;  13:192-199.
Alternative regimens: Higher dose, Longer duration
Beloqui O, Prieto J, Suarez M, Gil B, Qian CH, Garcia N, Civeira MP.  N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis  C: a pilot study. J Interferon Res 1993; 13:279-282.
Kakumu S, Yoshioka K, Wakita T, Ishikawa T, Takayanagi M, Higashi Y. A pilot  study of ribavirin and interferon beta for the treatment of chronic hepatitis C.  Gastroenterology 1993; 105:507- 512.
Liaw YF, Sheen IS, Lin SM, Chen TJ, Chu CM. Effects of prednisolone  pretreatment in interferon alfa therapy for patients with chronic non-A, non-B  (C) hepatitis. Liver 1993; 13:46-50.
Alternatives to Interferon
Camps J, Garcia N, Riezu-Boj JI, Civiera MP, Prieto J. Ribavirin in the  treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol  1993; 19:408-412.
Bodenheimer HC, Lindsay K, Davis GL, et al. Ribavirin treatment of chronic  hepatitis C. Hepatology 1994; 20:(abstract in press).
Decompensated Cirrhosis
Dimopoulou M, Fafoutis K, Basiliou K, Ketikoglou J, Karvountzis G.  Interferon alfa-2a for decompensated liver disease caused by wither chronic  hepatitis B or C: preliminary results of a pilot study. Gut 1993; 34 (suppl  2):S104-105.
HIV infected patients

Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. The  natural history of hepatitis C virus infection in multitransfused hemophiliacs:  Effects of coinfection with human immunodeficiency virus. Acquir Immune Defic  Syndr 1993; 6:602.
Eyster ME, Fried MW, DiBisceglie AM, Goedert JJ. Increasing HCV RNA levels  in hemophiliacs: Relationship to HIV infection and liver disease. Blood 1994;  (in press).
Boyer N, Marcellin P. Degott C, Degos F, Saimot AG, Erlinger S, Benhamou JP.  Recombinant interferon-alpha for chronic hepatitis C in patients positive for  antibody to human immunodeficiency virus. J Infect Dis 1992; 165:723-726.
Makis M, Preston FR, Triger DR, Underwood JC, Westlake L, Adelman MI. A  randomized controlled trial of recombinant interferon-alpha in chronic hepatitis  C in hemophiliacs. Blood 1991; 78:1672-1677.
Transplant Recipients
Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading  to hepatic failure in a patients with organ- transmitted hepatitis C virus  infection. Gastroenterology 1994; 106:248-251.
Ferrel LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral  infection in liver transplant recipients. Hepatology 1992; 16:865-876.
Wright HI, Gavaler JS, Van Thiel DH. Preliminary experience with alpha-2b  interferon therapy of viral hepatitis in liver allograft recipients.  Transplantation 1992; 53:121-124.
Asymptomatic Carriers
Naito M, Hayashi N, Hagiwara H, Hiram N, Kasahara A, Fusamato H, Kamada T. Serum  hepatitis C virus RNA quantity and histological features of hepatitis C virus  carriers with persistently normal ALT levels. Hepatology 1994; 19:871-875.
Extrahepatic Disease
Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases:  role of hepatitis C virus and liver damage. Gastroenterology 1994;  106:1291-1300.
Viladomiu L, Genesca J, Estaban JI, et al. Interferon alpha in acute  posttransfusion hepatitis C: a randomized controlled trial. Hepatology 1992;  15:767-769.
Omata M, Yokosuka O, Takano S et al. Resolution of acute hepatitis C after  therapy with natural beta interferon. Lancet 1991; 338:914-915.
Lampertico P, Rumi M, Romeo R, Craxi A, Soffrededini R, Biassoni D, Colombo  M. A multicenter randomized controlled trial of recombinant interferon alpha-2b  in patients with acute transfusion- associated hepatitis C. Hepatology 1994;  19:19-22.
Tassopoulos NC, Koutelou MG, Papatheodoridis G, et al. Recombinant human  interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993;  34:S130-132.



Related messages posted on the message board:

Why Interferons do NOT work (NIAID Study)
- April 27, 2003

The Center of Biologics Evaluation and Research review of PEG-Intron
- March 31, 2003

Lost in Maine
- January 8th, 2003

Disabling Problems Associated with Toxicity
- July 27, 2002

FDA approves Schering-Plough hepatitis-C combo package
- August 08, 2001

Suprisingly low impact of Interferon on Hepatitis C patients in a metropolitan hospital liver clinic setting
- Jan 01, 2001

Drug companies suppressing or manipulating the results...
- Jan 07, 2001

Enzon Trials 
- Feb 05, 2001

Hep C Pharmacy | Cancer Pharmacy | Order Book | Awards | Thymus

These statements are not intended to promote, sell, advertise
or otherwise induce anyone to purchase any product on this web site.

These statements have NOT been evaluated by the FDA
and are for informational purposes only.

All images ©2001 Lloyd Wright
Website maintained by FluxRostrum